Spruce Biosciences, Inc. (SPRB) Tops Q2 EPS by 10c

Spruce Biosciences, Inc. (NASDAQ: SPRB) reported Q2 EPS of ($0.22), $0.10 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $1.61 million versus the consensus estimate of $1.5 million.

For earnings history and earnings-related data on Spruce Biosciences, Inc. (SPRB) click here.

You May Also Be Interested In

• Trump Bought At Least $100,001 In Palantir Shares, Disclosure Shows - Bloomberg
• After-Hours Stock Movers: NKE, BE, STZ, RIG
• Flash Sports & Media Holdings (FLZH) files for 62.67M share offering by selling stockholders